3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Nonhematologic Malignancies
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Somatostatinoma
1
Sarcoma, Synovial
1
Sarcoma
1
Recurrent Lung Squamous Cell Carcinoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Non-hematologic Malignancy
1
Neurofibrosarcoma
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer
1
Meningeal Neoplasms
1
Lymphoma
1
Liver Neoplasms
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hematologic Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Interventions
Cyclophosphamide
27
fludarabine phosphate
19
Whole-Body Irradiation
18
Peripheral Blood Stem Cell Transplantation
18
Etoposide
17
Rituximab
15
Brentuximab Vedotin
15
Mycophenolic Acid
14
Tacrolimus
13
Doxorubicin
12
Vincristine
11
Prednisone
11
Methotrexate
11
Busulfan
11
Melphalan
9
Antilymphocyte Serum
9
Cyclosporine
8
Filgrastim
6
Carboplatin
6
Sirolimus
5
Radiotherapy
5
Lenalidomide
5
Gene Expression Profiling
5
Cytarabine
5
merphos
4
Vorinostat
4
Immunohistochemistry
4
Ifosfamide
4
Gemcitabine
4
Flow Cytometry
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Large-Cell, Anaplastic
×
sapanisertib
×
Clear all
No trials found.